Cignarelli, A <br/><br/>
Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cells.  [electronic resource] 

 -  Nutrition, metabolism, and cardiovascular diseases : NMCD  Apr 2016 
 - 333-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1590-3729 
<br/><br/><label>Standard No.: </label>10.1016/j.numecd.2015.11.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipocytes--cytology<br/>Adipogenesis--drug effects<br/>Adiponectin--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Apoptosis Regulatory Proteins<br/>CCAAT-Enhancer-Binding Protein-beta--genetics<br/>Cell Differentiation--drug effects<br/>Female<br/>Glucose Transporter Type 4--genetics<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--metabolism<br/>Insulin Detemir--pharmacology<br/>Insulin, Long-Acting--pharmacology<br/>Intra-Abdominal Fat--cytology<br/>Lipogenesis--drug effects<br/>Male<br/>Middle Aged<br/>PPAR gamma--genetics<br/>Proteins--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>RNA, Messenger--genetics<br/>Signal Transduction<br/>Stem Cells--drug effects<br/>Subcutaneous Fat--cytology